about
Clinical classification of cases of toxic epidermal necrolysis, Stevens-Johnson syndrome, and erythema multiformeMortality associated with neurofibromatosis 1: a cohort study of 1895 patients in 1980-2006 in FranceTypology of the primary outcome construction in dermatology: a systematic review of published randomized controlled trialsImpact of STROBE statement publication on quality of observational study reporting: interrupted time series versus before-after analysis.Clinical heterogeneity of duchenne muscular dystrophy (DMD): definition of sub-phenotypes and predictive criteria by long-term follow-up.Risk factors for erysipelas of the leg (cellulitis): case-control study.Impact of comprehensive geriatric assessment on survival, function, and nutritional status in elderly patients with head and neck cancer: protocol for a multicentre randomised controlled trial (EGeSOR)Risk prediction score for severe high altitude illness: a cohort study.Evolving pattern of drug-induced toxic epidermal necrolysis.Paresis acquired in the intensive care unit: a prospective multicenter study.Incidence of new-onset and flare of preexisting psoriasis during rituximab therapy for rheumatoid arthritis: data from the French AIR registry.Optimal management of elderly cancer patients: usefulness of the Comprehensive Geriatric Assessment.Risk factors for Gram-negative bacterial infections in febrile neutropenia.Impact of invasive fungal disease on the chemotherapy schedule and event-free survival in acute leukemia patients who survived fungal disease: a case-control studyCutaneous malignant melanoma, sun exposure, and sunscreen use: epidemiological evidence.Combination therapy with clindamycin and rifampicin for hidradenitis suppurativa: a series of 116 consecutive patients.At-risk phenotype of neurofibromatose-1 patients: a multicentre case-control study.Aging-related systemic manifestations in COPD patients and cigarette smokers.Hormonal status in protracted critical illness and in-hospital mortalityDiuretic versus placebo in normotensive acute pulmonary embolism with right ventricular enlargement and injury: a double-blind randomised placebo controlled study. Protocol of the DiPER study.Long-term mortality in older patients discharged after acute decompensated heart failure: a prospective cohort study.Clinical characteristics predicting internal neurofibromas in 357 children with neurofibromatosis-1: results from a cross-selectional study.Optimizing the G8 Screening Tool for Older Patients With Cancer: Diagnostic Performance and Validation of a Six-Item Version.Shortened telomeres in circulating leukocytes of patients with chronic obstructive pulmonary disease.Assessment of solid cancer treatment feasibility in older patients: a prospective cohort study.Determinants for the use of ambulation AIDS in a geriatric rehabilitation care unit: a retrospective study.Prognostic value of histologic features of toxic epidermal necrolysis.Systematic review of treatments for Stevens-Johnson syndrome and toxic epidermal necrolysis using the SCORTEN score as a tool for evaluating mortality.Possible relation of Tunisian pemphigus with traditional cosmetics: a multicenter case-control study.Comparative epidemiology of pemphigus in Tunisia and France: unusual incidence of pemphigus foliaceus in young Tunisian women.Genotypic influences on severity of exudative age-related macular degeneration.Results of platinum-based chemotherapy in unselected performance status (PS) 2 patients with advanced non-small cell lung cancer: a cohort study.Early chemotherapy discontinuation and mortality in older patients with metastatic bladder cancer: The AGEVIM multicenter cohort study.Four Distinct Health Profiles in Older Patients With Cancer: Latent Class Analysis of the Prospective ELCAPA Cohort.Interrelations between body mass index, frailty, and clinical adverse events in older community-dwelling women: The EPIDOS cohort study.Accuracy of the G-8 geriatric-oncology screening tool for identifying vulnerable elderly patients with cancer according to tumour site: the ELCAPA-02 study.Combined Plasma Elevation of CRP, Intestinal-Type Fatty Acid-Binding Protein (I-FABP), and sCD14 Identifies Older Patients at High Risk for Healthcare-Associated Infections.Performance and economic evaluation of the molecular detection of pathogens for patients with severe infections: the EVAMICA open-label, cluster-randomised, interventional crossover trial.A new workflow for the microbiological diagnosis of febrile neutropenia in patients with a central venous catheter.Chronological Age and Risk of Chemotherapy Nonfeasibility: A Real-Life Cohort Study of 153 Stage II or III Colorectal Cancer Patients Given Adjuvant-modified FOLFOX6.
P50
Q21128682-5F77F823-29F9-4FAA-8FCC-28B94362E440Q21202873-145493CD-7E2C-4FBF-BD00-65A3ADE4E5A1Q26864790-9A6FAD86-001B-4A80-8B75-713EB711559DQ31130060-78B34CAB-3B69-4826-AB4B-09DD6B1197EAQ33405753-7F68FFEB-D7FC-485D-9369-10CA76B9BA72Q33620263-B6233C7E-3474-4F8C-A242-E3B61E6D0BB2Q33844620-4213CE59-1864-44D0-946A-F6C9E1585DE3Q33961032-2FE2F31B-7BAA-4EE6-8810-E958883ECA6DQ34061746-CF5CBAE8-813E-4DDB-B76D-D7AA1777B26CQ34163357-1220809E-7AA4-4EED-A7D5-8A0580991D0DQ34233372-0257144E-BC4E-4BF3-9B31-807085361BB8Q34306560-8ADF8FB3-5B1D-4A06-9CEA-D069207A3EA6Q34440016-4A44821C-8D5B-4E3A-AC2B-D7C915884F9DQ34543097-69C1B75C-36C8-4F89-84D4-26D85897ECADQ34609528-AE8F392E-7781-4030-9425-587F5F58AF28Q34991622-341FB6E7-04F5-4D78-AF13-5EA66C7160E6Q35145718-79F437B2-D5D1-4C3B-9AE1-B14CD1654293Q35192574-0E8DBCDB-E2B4-4231-B112-A9DF82D29D7AQ35566951-1106E174-7E94-4E64-9929-41B024F3B5EAQ35640274-C655BBA4-7DE4-4AE5-AC61-D1360B60C1F7Q36261618-0D60062E-07E4-4F9E-B4B2-212ADFA71A98Q36369566-C87A0F63-88CA-462A-9156-4751A16D7C2BQ36558425-EB39B7C2-82D2-4303-8E56-093C35908CDCQ36849827-38BB07BF-F42C-4E20-A274-E3557D7C9D46Q37644543-26A14A22-427A-4D0D-9A89-A467498280C6Q37859472-387C7C1F-66AA-48A0-B2B4-EAFBD2C234C0Q37956766-E8651A4C-A4CE-4081-BCD8-E6AF3E304085Q38235949-2269A6F1-E564-4175-86B4-8FF9BF241C50Q38896305-F2DE106F-9573-4914-B843-4781A597976BQ38896311-4C94B3EF-DF5C-4E70-9C48-FED4FF03497FQ39172877-9773F965-7F27-4050-8A6E-EE900ECF1722Q39229999-4A407EC6-58C1-455F-A49D-2BB82B5DE732Q39308532-7B624953-CB73-410D-B2EC-DC9923E52CD3Q39896359-5B4559ED-DDCC-454B-BC2B-76FBD77E80DDQ40069145-B7DFD9B9-5432-4D26-AF7E-5BEB6D30EFF8Q40168233-EE0214F1-723F-4508-AE71-05AFEFED5CBBQ40172597-F2188623-6A1D-48F4-8111-6F9A86056BB9Q40259721-F426A254-7DDA-4CF3-ABA0-2449BE3D5869Q40267223-722BF1C9-E9DE-4042-96DC-E1F066F60257Q40337825-4200B043-9CB1-4CA3-8584-0DDEDD9E20A2
P50
description
Frans epidemiologe
@nl
French epidemiologist
@en
հետազոտող
@hy
name
Sylvie Bastuji-Garin
@ast
Sylvie Bastuji-Garin
@en
Sylvie Bastuji-Garin
@es
Sylvie Bastuji-Garin
@nl
Sylvie Bastuji-Garin
@sl
type
label
Sylvie Bastuji-Garin
@ast
Sylvie Bastuji-Garin
@en
Sylvie Bastuji-Garin
@es
Sylvie Bastuji-Garin
@nl
Sylvie Bastuji-Garin
@sl
prefLabel
Sylvie Bastuji-Garin
@ast
Sylvie Bastuji-Garin
@en
Sylvie Bastuji-Garin
@es
Sylvie Bastuji-Garin
@nl
Sylvie Bastuji-Garin
@sl
P1053
R-3479-2018
P106
P1412
P2038
Sylvie_Bastuji-Garin
P21
P27
P31
P3829
P496
0000-0001-9855-5183